Showing results (501-510 of 10,660) with videos related to

Sort By:
Pageof 1,066
Metabolism: Clinical and Experimental|August 4, 2015
Nonalcoholic fatty liver disease and statinsKonstantinos Tziomalos, Vasilios G Athyros, Paschalis Paschos, et al.
Metabolism: Clinical and Experimental|November 1, 1989
A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of ratsE W Kraegen, D E James, A B Jenkins, et al.
Metabolism: Clinical and Experimental|January 17, 2016
Treatment with atorvastatin attenuates progression of insulin resistance and pancreatic fibrosis in the Otsuka Long-Evans Tokushima fatty ratsLimin Wei, Mitsuyoshi Yamamoto, Masaru Harada, et al.
Metabolism: Clinical and Experimental|January 17, 2016
Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: A Kangbuk Samsung Health StudyEun-Jung Rhee, Se Eun Park, Yoosoo Chang, et al.
Metabolism: Clinical and Experimental|January 17, 2016
Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphateDong-Sung Lee, Eun-Sol Lee, Md Morshedul Alam, et al.
Metabolism: Clinical and Experimental|January 17, 2016
Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2Emily C Graff, Han Fang, Desiree Wanders, et al.
Metabolism: Clinical and Experimental|October 1, 1989
Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemiaP W Stacpoole, J Alig, L Ammon, et al.
Metabolism: Clinical and Experimental|October 1, 1989
Different localization of early arterial lesions in insulin-dependent diabetes mellitus and in familial hypercholesterolemiaP Rubba, G Riccardi, P Pauciullo, et al.
Metabolism: Clinical and Experimental|December 20, 2015
Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutideEugenia Lampropoulou, Anna Lymperopoulou, Aristidis Charonis
Metabolism: Clinical and Experimental|December 20, 2015
A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic miceNoriyuki Naya, Keita Fukao, Akemi Nakamura, et al.
Pageof 1,066